Tags : ~$11.5B

Thermo Fisher Scientific to Acquire QIAGEN for ~$11.5B

Shots: Thermo Fisher to acquire QIAGEN in an all-cash transaction for $43.3/ share, making a total deal value ~$11.5B with a premium of 23% to the closing price of QIAGEN’s common stock on the Frankfurt Prime Standard on Mar 02, 2020. The transaction is expected to be completed in H1’21 The focus of the acquisition […]Read More